Keywords
kidney transplantation
BK-poliomavirus infection
cyclosporine A
tacrolimus
How to Cite
Abstract
The incidence of BK-poliomavirus infection was studied in the first year of the posttransplant period, taking into account the nosological forms and the influence of immunosuppressors. Forty six recipients of renal transplant were examined, 7 (15.21 %) cases of viruria and 5 (10.86 %) cases of viremia of BK-poliomavirus were revealed. Viremia and viruria was significantly higher in patients receiving tacrolimus than in patients in the scheme of immunosuppressive drugs is cyclosporine A. There was a significant increase in the incidence of viruria in transplanted patients with diabetes mellitus during the first year after operation. The conversion of immunosuppressive therapy from cyclosporine to tacrolimus can be recommended to improve graft survival in the posttransplant period.
References
Bohl D.L., Brennan D.C. (2007). BK virus nephropathy and kidney transplantation. Clin. J. Am. Soc. Nephrol., vol. 2 (1), pp. S36–S46.
Knowles W.A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D.W., Miller E. (2003). Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol., vol. 71, pp. 115–123.
Ranjan R., Rani A., Brennan D.C., Finn P.W., Perkins D.L. (2017). Complete genome sequence of BK polyomavirus subtype Ib-1 detected in a kidney transplant patient with BK viremia using shotgun sequencing. Genome Announc., vol. 5 (6), pii e01474–16.
Anzivino E., Bellizzi A., Mitterhofer A.P., Tinti F., Barile M., Colosimo M.T. et al. (2011). Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab. Virol. J., vol. 8, pp. 407.
Egli A., Infanti L., Dumoulin A., Buser A., Samaridis J., Stebler C. (2009). Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis., vol. 199, pp. 837–846.
Beimler J., Sommerer C., Zeier M. (2007). The influence of immunosuppression on the development of BK virus nephropathy – does it matter? Nephrol. Dial. Transplant., vol. 22 (8), pp. 66–71.
Comoli P., Cioni M., Basso S., Gagliardone C., Potenza L., Verrina E. et al. (2013). Immunity to polyomavirus BK infection: immune monitoring to regulate the balance between risk of BKV nephropathy and induction of alloimmunity. Clin. Dev. Immunol., vol. 2013, pp. 256923.
Garces J.C. (2010). BK virus-associated nephropathy in kidney transplant recipients. Ochsner. J., vol. 10, pp. 245–249.
Sawinski D., Goral S. (2015). BK virus infection: an update on diagnosis and treatment. Nephrol. Dial. Transplant., vol. 30, pp. 209–217.
Shah K.V. (2000). Human polyomavirus BKV and renal disease. Nephrol. Dial. Transplant., vol. 15 (6), pp. 754–755.
Randhawa P., Brennan D.C. (2006). BK virus infection in transplant recipients: an overview and update. American Journal of Transplantation, vol. 6 (9), pp. 2000–2005.
Hirsch H.H., Vincenti F., Friman S., Tuncer M., Citterio F., Wiecek A. et al. (2013). Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am. J. Transplant., vol. 13, pp. 136–145.